Cornell University;Sloan Kettering Institute For Cancer Research
发明人:
申请号：
EP17156149.1
公开号：
EP3208615A2
申请日:
2012.07.06
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
This invention concerns various methods of using labeled HSP90 inhibitors to improve treatment of cancer patients with HSP90 inhibitors, including ex vivo and in vivo methods for determining whether a tumor will likely respond to therapy with an HSP90 inhibitor. Regimens of the drug PU-H71 are also disclosed.
